Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
ANIX	ANIXA BIOSCIENCES INC	$2.79	0.00%	3.33%	2.20%	-0.36%	-23.77%	-9.71%	-15.45%	51.63%	-7.00%	$4.20	$2.07	33.57%	34.78%	0.92	34,628	-34.73%
GERN	GERON CORP	$1.43	1.42%	0.70%	-3.38%	-49.82%	-65.21%	-64.95%	-4.03%	21.19%	-63.61%	$5.34	$1.17	73.22%	22.22%	1.14	7,838,644	-9.65%
THRD	THIRD HARMONIC BIO INC	$5.16	-0.19%	0.39%	53.57%	2.58%	-63.99%	-54.66%	N/A	N/A	N/A	$16.94	$3.18	69.54%	62.26%	0.78	313,436	3.07%
WHWK	WHITEHAWK THERAPEUTICS INC	$1.67	12.84%	10.60%	-1.76%	-39.05%	-16.08%	-13.92%	-89.38%	-81.77%	N/A	$3.81	$1.21	56.19%	38.02%	0.76	1,454,431	5,146.11%
AVBP	ARRIVENT BIOPHARMA INC	$21.08	-0.85%	-0.43%	16.92%	-23.51%	-31.51%	26.30%	N/A	N/A	N/A	$36.37	$15.47	42.04%	36.26%	0.82	124,257	-32.37%
SEPN	SEPTERNA INC	$7.14	2.59%	10.53%	42.23%	-54.26%	-67.23%	N/A	N/A	N/A	N/A	$28.99	$4.17	75.37%	71.22%	1.30	210,635	-26.35%
NRIX	NURIX THERAPEUTICS INC	$11.16	-3.21%	-3.13%	6.59%	-41.11%	-54.39%	-14.68%	-6.69%	N/A	N/A	$29.56	$8.18	62.25%	36.43%	1.51	679,165	-9.15%
BIVI	BIOVIE INC	$0.86	5.38%	-3.58%	2.62%	-46.13%	-68.88%	-82.52%	-97.61%	N/A	N/A	$7.50	$0.62	88.51%	39.03%	1.51	330,750	313.39%
PRTA	PROTHENA CORP PUBLIC LTD CO	$8.72	-5.22%	-9.64%	-25.72%	-35.12%	-47.63%	-59.29%	-71.53%	-23.31%	-74.09%	$25.42	$8.58	65.70%	1.63%	1.41	1,936,843	95.71%
ABSI	ABSCI CORP	$3.03	-1.30%	-5.90%	26.25%	-18.11%	-22.70%	-41.62%	-50.08%	N/A	N/A	$6.33	$2.01	52.13%	50.75%	2.11	1,524,599	-32.55%
ELVN	ENLIVEN THERAPEUTICS INC	$19.85	4.80%	8.47%	5.14%	-9.36%	-28.16%	9.67%	290.75%	-71.27%	N/A	$30.03	$13.30	33.90%	49.25%	0.94	216,036	36.90%
IFRX	INFLARX NV	$1.85	8.82%	40.15%	76.19%	-23.24%	17.09%	31.21%	12.12%	-73.53%	N/A	$2.82	$0.82	34.28%	124.51%	0.76	388,954	-25.21%
AKRO	AKERO THERAPEUTICS INC	$45.31	-0.66%	10.54%	17.26%	-15.86%	40.15%	125.65%	302.76%	114.84%	N/A	$58.40	$17.86	22.41%	153.70%	0.57	1,353,236	-8.61%
FBRX	FORTE BIOSCIENCES INC	$7.16	-1.88%	2.92%	-3.59%	-52.15%	71.36%	-57.30%	-75.09%	-98.37%	N/A	$28.68	$4.11	75.02%	74.28%	0.79	7,631	72.65%
VIR	VIR BIOTECHNOLOGY INC	$6.08	-0.65%	-3.34%	-1.62%	-39.08%	-34.34%	-30.43%	-70.85%	-78.20%	N/A	$14.45	$4.95	57.92%	22.83%	1.23	906,536	-2.00%
AUTL	AUTOLUS THERAPEUTICS PLC	$1.35	-4.26%	-3.57%	-4.26%	-36.02%	-61.43%	-66.25%	-58.33%	-85.00%	N/A	$5.00	$1.11	73.00%	22.17%	0.99	1,355,422	-21.83%
ICU	SEASTAR MEDICAL HOLDING CORP	$1.30	0.78%	1.56%	-13.33%	-42.98%	-57.10%	-88.83%	-99.49%	N/A	N/A	$13.85	$1.11	90.61%	17.12%	0.05	188,143	96.23%
EPIX	ESSA PHARMA INC	$1.77	-2.75%	-1.67%	13.46%	4.73%	26.43%	-73.26%	-69.80%	-60.67%	-98.83%	$7.88	$1.40	77.54%	26.43%	0.81	155,682	-14.09%
ALGS	ALIGOS THERAPEUTICS INC	$6.04	8.15%	3.52%	-15.48%	-73.26%	-36.81%	-68.65%	-81.29%	N/A	N/A	$46.80	$3.76	87.10%	60.51%	1.33	124,414	84.27%
CGON	CG ONCOLOGY INC	$27.74	2.97%	28.90%	25.80%	-5.52%	-22.75%	-31.71%	N/A	N/A	N/A	$46.99	$14.80	40.97%	87.43%	1.51	916,306	-44.94%
IBIO	IBIO INC	$1.03	-2.83%	21.61%	-73.66%	-67.09%	-61.42%	-44.32%	-99.32%	-99.81%	-99.98%	$6.89	$0.64	85.05%	61.95%	1.12	578,391	-58.11%
NVCT	NUVECTIS PHARMA INC	$9.62	-3.41%	-12.23%	2.89%	41.47%	50.08%	44.66%	3.33%	N/A	N/A	$11.80	$4.44	18.47%	116.67%	0.32	106,889	-24.74%
LIPO	LIPELLA PHARMACEUTICALS INC	$2.52	1.20%	-2.33%	-1.95%	-7.69%	-19.08%	-56.68%	N/A	N/A	N/A	$12.00	$1.97	79.00%	28.24%	0.60	6,873	32.10%
XFOR	X4 PHARMACEUTICALS INC	$3.75	-12.99%	-33.23%	-43.62%	-79.17%	-75.92%	-88.69%	-89.92%	-98.59%	N/A	$36.00	$3.70	89.58%	1.35%	1.19	263,586	-39.60%
NRXP	NRX PHARMACEUTICALS INC	$2.08	-1.89%	0.48%	7.22%	-25.71%	50.18%	-4.59%	-86.58%	-98.24%	N/A	$6.01	$1.10	65.39%	89.09%	0.87	72,813	-70.06%
MGX	METAGENOMI INC	$1.49	-13.87%	-14.86%	12.88%	-40.64%	-29.38%	-78.84%	N/A	N/A	N/A	$8.18	$1.23	81.77%	21.14%	0.63	1,198,726	299.96%
IRD	OPUS GENETICS INC	$0.94	-1.26%	17.25%	3.08%	-13.15%	-20.51%	-42.80%	-57.94%	-88.28%	-99.73%	$2.18	$0.65	56.97%	44.31%	0.80	115,138	-74.75%
CMPX	COMPASS THERAPEUTICS INC	$1.82	-2.15%	-14.15%	-18.75%	-40.91%	7.06%	15.92%	24.66%	N/A	N/A	$4.08	$0.77	55.39%	137.91%	0.94	503,239	4.34%
MLYS	MINERALYS THERAPEUTICS INC	$14.96	5.28%	6.17%	8.09%	50.65%	11.23%	16.88%	N/A	N/A	N/A	$18.38	$8.24	18.61%	81.53%	1.02	1,077,375	8.16%
TNYA	TENAYA THERAPEUTICS INC	$0.51	7.37%	10.63%	-6.25%	-51.43%	-73.71%	-89.10%	-94.64%	N/A	N/A	$4.96	$0.39	89.72%	29.44%	1.80	1,686,903	-1.57%
ACRV	ACRIVON THERAPEUTICS INC	$1.33	-5.00%	-33.17%	-20.83%	-76.12%	-83.40%	-83.84%	N/A	N/A	N/A	$10.29	$1.30	87.07%	2.31%	1.48	974,656	6.47%
IRON	DISC MEDICINE INC	$49.68	0.53%	7.60%	5.37%	-9.66%	5.41%	74.13%	220.52%	N/A	N/A	$68.73	$28.25	27.72%	75.89%	0.82	372,797	-14.88%
KROS	KEROS THERAPEUTICS INC	$14.57	0.90%	1.04%	52.57%	30.91%	-75.69%	-74.76%	-73.78%	-49.41%	N/A	$72.37	$9.12	79.87%	59.76%	1.13	689,118	-7.75%
IDYA	IDEAYA BIOSCIENCES INC	$20.47	1.69%	7.34%	38.59%	-13.41%	-28.43%	-50.29%	108.45%	289.16%	N/A	$44.42	$13.45	53.92%	52.19%	1.12	949,035	-14.22%
CELU	CELULARITY INC	$1.57	5.44%	-7.04%	-8.66%	-22.23%	9.10%	-47.98%	-98.65%	-98.41%	N/A	$5.22	$1.00	69.90%	56.94%	1.06	16,272	-30.38%
LQDA	LIQUIDIA CORP	$13.98	0.07%	-0.36%	-3.65%	-2.44%	27.32%	6.15%	139.79%	172.51%	N/A	$16.81	$8.26	16.84%	69.25%	0.98	667,004	-60.16%
HLVX	HILLEVAX INC	$1.93	-0.52%	4.32%	39.35%	1.05%	3.21%	-85.77%	-90.38%	N/A	N/A	$16.31	$1.34	88.16%	44.03%	1.09	319,309	-28.17%
ARWR	ARROWHEAD PHARMACEUTICALS INC	$14.04	1.08%	5.25%	15.03%	-25.08%	-27.96%	-39.40%	-67.39%	-56.88%	101.43%	$30.41	$9.57	53.83%	46.71%	1.56	1,233,435	-26.34%
LGVN	LONGEVERON INC	$1.56	-7.14%	-4.29%	4.00%	6.12%	-23.15%	-10.34%	-98.40%	N/A	N/A	$6.40	$0.77	75.63%	102.33%	1.21	233,971	138.80%
MBX	MBX BIOSCIENCES INC	$11.28	7.53%	21.68%	64.43%	7.53%	-49.78%	N/A	N/A	N/A	N/A	$27.50	$4.81	58.98%	134.66%	1.42	277,052	-19.87%
MBRX	MOLECULIN BIOTECH INC	$1.01	-4.72%	-9.01%	5.32%	-27.34%	-58.78%	-80.04%	-95.79%	-98.95%	N/A	$5.44	$0.40	81.43%	153.77%	0.84	107,306	-44.35%
IMNM	IMMUNOME INC	$8.86	0.80%	3.99%	41.53%	-14.15%	-23.55%	-39.69%	130.73%	N/A	N/A	$16.81	$5.15	47.29%	72.04%	1.41	717,272	-35.98%
QNRX	QUOIN PHARMACEUTICALS LTD	$6.61	-2.42%	-0.42%	56.07%	11.95%	-56.45%	-53.50%	-99.73%	-99.98%	N/A	$31.40	$3.33	78.96%	98.47%	2.13	18,936	-59.90%
CRBU	CARIBOU BIOSCIENCES INC	$0.80	-5.76%	-8.13%	-4.64%	-41.46%	-63.71%	-78.27%	-89.89%	N/A	N/A	$3.93	$0.66	79.59%	21.52%	1.75	769,893	-2.11%
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	$18.04	0.17%	4.94%	3.38%	-7.44%	29.50%	-96.81%	-99.98%	-100.00%	-100.00%	$672.00	$6.76	97.32%	166.86%	1.03	515,031	-15.14%
CLSD	CLEARSIDE BIOMEDICAL INC	$0.85	-1.50%	0.35%	-6.17%	-9.36%	-15.64%	-32.91%	-48.36%	-55.85%	N/A	$1.65	$0.70	48.36%	21.71%	0.87	64,575	-15.59%
NGNE	NEUROGENE INC	$15.40	2.67%	0.20%	59.50%	-8.55%	-66.57%	-54.40%	-38.40%	-92.78%	-88.90%	$74.49	$6.88	79.33%	124.00%	1.37	98,842	-41.47%
ATRA	ATARA BIOTHERAPEUTICS INC	$7.56	-5.38%	-0.53%	25.79%	-11.27%	-22.14%	-55.82%	-95.64%	-96.18%	-99.25%	$18.71	$5.01	59.58%	51.05%	1.86	16,309	-60.07%
URGN	UROGEN PHARMA LTD	$11.41	-1.98%	12.86%	7.34%	1.78%	-6.48%	-20.76%	71.32%	-47.95%	N/A	$20.70	$8.94	44.88%	27.63%	0.84	532,028	-31.17%
NKTX	NKARTA INC	$2.05	-3.30%	-6.82%	11.11%	-5.53%	-35.74%	-72.63%	-89.08%	N/A	N/A	$8.33	$1.31	75.39%	56.49%	1.45	421,994	-25.28%
VERV	VERVE THERAPEUTICS INC	$5.50	-3.00%	-4.84%	33.01%	-26.86%	-7.25%	-8.33%	-64.56%	N/A	N/A	$9.31	$2.87	40.89%	91.97%	1.99	2,186,340	6.23%
TELO	TELOMIR PHARMACEUTICALS INC	$2.51	-1.57%	-1.95%	-8.39%	-39.81%	-40.94%	-63.22%	N/A	N/A	N/A	$8.40	$2.35	70.12%	6.63%	0.96	139,077	5.54%
DRMA	DERMATA THERAPEUTICS INC	$0.82	-2.03%	9.47%	-17.90%	-33.25%	-32.98%	-83.54%	-99.66%	N/A	N/A	$6.17	$0.69	86.70%	18.99%	0.51	105,102	-70.51%
MTSR	METSERA INC	$23.36	-3.11%	10.29%	-4.69%	-15.97%	N/A	N/A	N/A	N/A	N/A	$32.81	$12.30	28.80%	89.92%	1.56	705,959	-18.95%
KRRO	KORRO BIO INC	$18.40	3.63%	5.48%	15.33%	-45.09%	-68.37%	-69.84%	-70.57%	-97.62%	N/A	$98.00	$11.13	81.23%	65.27%	1.11	69,677	-27.28%
BEAM	BEAM THERAPEUTICS INC	$19.83	-0.50%	-1.69%	12.45%	-22.51%	-13.52%	-8.79%	-51.37%	28.93%	N/A	$35.25	$13.53	43.74%	46.62%	1.90	1,605,188	-23.02%
DSGN	DESIGN THERAPEUTICS INC	$4.71	-3.09%	11.08%	30.65%	-0.21%	-9.42%	30.11%	-62.14%	N/A	N/A	$7.77	$2.60	39.38%	81.15%	1.42	215,383	-30.14%
INMB	INMUNE BIO INC	$7.59	-3.44%	-5.60%	0.00%	-22.23%	25.66%	-34.57%	-3.92%	59.79%	N/A	$11.76	$4.32	35.45%	75.69%	1.37	175,926	4.74%
DMAC	DIAMEDICA THERAPEUTICS INC	$4.13	-0.48%	-0.96%	10.13%	-30.00%	-2.82%	59.46%	64.54%	3.98%	N/A	$6.82	$2.14	39.43%	92.99%	0.77	64,205	34.93%
NAUT	NAUTILUS BIOTECHNOLOGY INC	$0.69	-0.58%	-3.93%	-17.47%	-59.94%	-73.75%	-75.36%	-85.85%	N/A	N/A	$3.09	$0.66	77.83%	3.79%	1.51	121,734	-38.52%
CLYM	CLIMB BIO INC	$1.26	-5.97%	-3.08%	5.00%	-36.68%	-67.02%	-83.36%	-64.20%	N/A	N/A	$11.55	$1.05	89.09%	20.00%	0.68	77,820	-57.90%
COEP	COEPTIS THERAPEUTICS HOLDINGS INC	$8.30	-1.19%	-33.44%	-12.35%	-28.32%	109.60%	22.13%	-95.89%	N/A	N/A	$13.70	$2.31	39.42%	259.31%	0.33	35,291	-89.04%
TVGN	TEVOGEN BIO HOLDINGS INC	$0.98	-5.05%	-3.17%	-10.28%	-33.01%	-58.73%	0.82%	-90.24%	N/A	N/A	$3.09	$0.26	68.35%	282.03%	0.39	1,522,017	-34.71%
ATOS	ATOSSA THERAPEUTICS INC	$0.84	-6.12%	15.01%	29.49%	-0.47%	-40.63%	-44.90%	-16.53%	-59.86%	-99.67%	$1.81	$0.55	53.43%	52.44%	1.31	913,841	-16.25%
PRAX	PRAXIS PRECISION MEDICINES INC	$38.06	1.12%	5.72%	6.11%	-52.58%	-44.30%	-31.00%	-71.17%	N/A	N/A	$91.83	$26.70	58.55%	42.55%	1.13	276,938	-53.02%
ALLO	ALLOGENE THERAPEUTICS INC	$1.69	0.60%	7.64%	23.36%	1.20%	-37.87%	-42.12%	-81.45%	-94.06%	N/A	$3.78	$1.23	55.29%	37.40%	1.38	1,501,817	-75.19%
VSTM	VERASTEM INC	$7.43	-0.80%	-0.93%	27.66%	30.12%	89.54%	-25.55%	-57.30%	-64.62%	-92.74%	$13.52	$2.10	45.04%	253.81%	1.55	1,058,280	-34.79%
XENE	XENON PHARMACEUTICALS INC	$38.09	-0.29%	-0.29%	24.31%	-3.69%	-8.64%	-10.36%	31.12%	208.17%	183.83%	$46.00	$26.74	17.20%	42.45%	0.80	964,335	-4.25%
STRO	SUTRO BIOPHARMA INC	$1.07	1.90%	-17.69%	79.83%	-43.68%	-69.86%	-71.39%	-83.79%	-88.71%	N/A	$5.17	$0.52	79.30%	104.59%	1.38	1,619,133	-44.79%
ADTX	ADITXT INC	$2.15	-2.71%	-6.52%	-52.43%	-92.18%	-98.38%	-99.99%	-100.00%	N/A	N/A	$27.20k	$2.04	99.99%	5.39%	0.54	72,639	-35.74%
TRVI	TREVI THERAPEUTICS INC	$6.90	-0.14%	8.66%	14.81%	63.51%	129.24%	141.26%	174.90%	156.51%	N/A	$7.39	$2.30	6.63%	200.00%	0.74	1,827,238	15.90%
JANX	JANUX THERAPEUTICS INC	$32.05	-3.46%	-0.06%	19.54%	-23.82%	-41.07%	-44.92%	209.96%	N/A	N/A	$71.71	$22.52	55.31%	42.32%	1.52	1,043,397	11.13%
PRTG	PORTAGE BIOTECH INC	$10.76	-9.20%	16.07%	30.27%	139.11%	92.83%	133.91%	-89.96%	N/A	N/A	$23.01	$2.10	53.24%	412.87%	1.11	208,645	-52.01%
DAWN	DAY ONE BIOPHARMACEUTICALS INC	$7.62	-2.06%	-3.54%	0.13%	-36.87%	-47.99%	-56.92%	-17.89%	N/A	N/A	$18.00	$6.41	57.67%	18.88%	0.74	1,281,770	-0.70%
SAGE	SAGE THERAPEUTICS INC	$7.48	2.61%	-3.98%	-4.83%	3.03%	23.64%	-43.67%	-77.06%	-79.85%	-86.31%	$14.31	$4.62	47.73%	61.90%	1.11	1,317,843	-0.99%
VRAX	VIRAX BIOLABS GROUP LTD	$0.98	0.00%	-10.09%	-10.75%	-41.32%	-51.96%	51.00%	N/A	N/A	N/A	$9.00	$0.60	89.11%	63.33%	0.67	365,340	479.96%
GANX	GAIN THERAPEUTICS INC	$2.18	6.34%	15.96%	20.44%	0.93%	-6.03%	-26.60%	-35.69%	N/A	N/A	$3.19	$0.89	31.66%	144.94%	1.07	929,476	55.12%
PEPG	PEPGEN INC	$1.47	-6.37%	-12.50%	12.21%	17.60%	-77.31%	-89.42%	N/A	N/A	N/A	$19.30	$0.88	92.38%	67.05%	1.25	192,737	-34.75%
SLN	SILENCE THERAPEUTICS PLC	$4.01	8.38%	14.25%	65.70%	-20.75%	-77.32%	-81.28%	-69.74%	N/A	N/A	$24.38	$1.97	83.55%	103.55%	0.61	237,984	25.83%
AVTX	AVALO THERAPEUTICS INC	$5.04	1.20%	3.28%	-26.42%	-37.16%	-61.13%	-68.50%	-99.58%	-99.92%	N/A	$16.00	$4.15	68.50%	21.45%	0.89	32,889	-49.00%
ANRO	ALTO NEUROSCIENCE INC	$2.45	-1.61%	7.46%	21.29%	-41.39%	-38.44%	-84.78%	N/A	N/A	N/A	$17.55	$1.60	86.04%	53.13%	0.73	148,186	9.87%
MBIO	MUSTANG BIO INC	$1.11	1.83%	-10.48%	-14.15%	-72.25%	-91.69%	-91.46%	-99.80%	-99.94%	N/A	$65.00	$1.01	98.29%	9.90%	1.65	131,179	-72.37%
SRRK	SCHOLAR ROCK HOLDING CORP	$32.76	-0.46%	-4.71%	8.98%	-18.20%	15.27%	118.98%	328.80%	117.82%	N/A	$46.98	$6.76	30.27%	384.62%	0.79	973,484	-30.78%
CNSP	CNS PHARMACEUTICALS INC	$1.06	-2.30%	1.92%	-17.83%	-77.96%	-81.17%	-99.81%	-100.00%	-100.00%	N/A	$800.00	$0.77	99.87%	37.31%	0.65	99,551	-1.02%
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$7.52	0.67%	-9.94%	49.50%	-20.93%	-55.56%	-79.81%	-25.75%	-95.84%	-92.07%	$61.90	$4.64	87.85%	62.07%	1.51	146,832	11.20%
RNA	AVIDITY BIOSCIENCES INC	$32.69	0.12%	5.69%	22.25%	2.28%	-21.93%	26.71%	116.49%	N/A	N/A	$56.00	$21.51	41.63%	51.98%	1.14	1,102,603	26.69%
SANA	SANA BIOTECHNOLOGY INC	$1.90	0.00%	7.34%	26.67%	-37.91%	-48.09%	-80.27%	-75.70%	N/A	N/A	$10.50	$1.26	81.90%	50.79%	2.06	1,670,884	-42.12%
IGMS	IGM BIOSCIENCES INC	$1.34	-3.25%	-2.90%	16.52%	-6.29%	-91.74%	-85.86%	-92.98%	-97.54%	N/A	$22.50	$0.92	94.04%	45.65%	1.58	43,879	-75.39%
ZNTL	ZENTALIS PHARMACEUTICALS INC	$1.45	2.11%	-3.97%	4.32%	-13.69%	-56.33%	-87.18%	-94.64%	-95.37%	N/A	$13.24	$1.01	89.05%	43.56%	1.53	696,943	-5.52%
NNVC	NANOVIRICIDES INC	$1.33	-2.92%	-1.48%	14.66%	13.68%	-6.34%	17.70%	-14.19%	-76.99%	-96.41%	$3.59	$0.94	62.95%	41.49%	0.81	75,256	-20.79%
VTGN	VISTAGEN THERAPEUTICS INC	$2.36	0.85%	0.85%	0.85%	-18.90%	-24.12%	-50.21%	-93.85%	-80.58%	N/A	$4.75	$1.90	50.32%	24.21%	1.65	60,619	-46.77%
PHAT	PHATHOM PHARMACEUTICALS INC	$3.36	-21.68%	-18.45%	-34.38%	-40.32%	-81.61%	-63.71%	-75.93%	-89.33%	N/A	$19.71	$3.07	82.95%	9.45%	1.38	5,497,210	364.71%
NTLA	INTELLIA THERAPEUTICS INC	$8.64	-2.59%	5.62%	29.83%	-9.43%	-41.66%	-61.60%	-83.26%	-31.54%	N/A	$28.18	$5.90	69.34%	46.44%	1.90	2,125,424	-49.72%
MNPR	MONOPAR THERAPEUTICS	$43.15	3.18%	-3.19%	29.08%	-0.92%	194.94%	1,227.69%	276.86%	20.70%	N/A	$54.30	$1.72	20.53%	2,410.18%	0.74	9,724	-30.03%
ACET	ADICET BIO INC	$0.63	-5.14%	2.28%	-14.56%	-29.99%	-49.76%	-58.68%	-95.89%	-94.02%	N/A	$1.87	$0.45	66.33%	40.49%	1.20	338,564	123.73%
FBLG	FIBROBIOLOGICS INC	$1.02	-8.93%	-20.93%	18.60%	-37.04%	-67.92%	-87.14%	N/A	N/A	N/A	$13.59	$0.76	92.49%	33.68%	0.19	99,842	-54.71%
CRSP	CRISPR THERAPEUTICS AG	$37.73	-2.43%	-3.53%	13.85%	-5.68%	-25.67%	-29.88%	-27.41%	-22.14%	N/A	$67.88	$30.04	44.42%	25.60%	1.44	1,935,797	-7.11%
OLMA	OLEMA PHARMACEUTICALS INC	$5.29	2.52%	3.73%	58.38%	-11.24%	-54.48%	-49.13%	97.39%	N/A	N/A	$16.62	$2.86	68.17%	84.97%	1.33	762,280	7.79%
OMER	OMEROS CORP	$7.02	-4.49%	-3.84%	-11.25%	-16.73%	72.06%	106.47%	108.31%	-56.48%	-65.64%	$13.60	$3.00	48.38%	134.00%	1.48	542,628	46.94%
REVB	REVELATION BIOSCIENCES INC	$3.02	-1.05%	3.00%	16.08%	-24.36%	-77.08%	-91.23%	-99.98%	N/A	N/A	$60.80	$2.36	95.04%	27.88%	1.01	19,980	-49.82%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Protalix Biotherapeutics (NYSEMKT:PLX)

Protalix Biotherapeutics (NYSEMKT:PLX) is the #1 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Protalix Biotherapeutics (NYSEMKT:PLX) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: B.

Protalix Biotherapeutics (NYSEMKT:PLX) has a Due Diligence Score of 23, which is -1 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates PLX as a "A".

PLX passed 7 out of 33 due diligence checks and has weak fundamentals. Protalix Biotherapeutics has seen its stock return 147.93% over the past year, overperforming other biotech stocks by 225 percentage points.

Protalix Biotherapeutics has an average 1 year price target of $15.00, an upside of 400% from Protalix Biotherapeutics's current stock price of $3.00.

Protalix Biotherapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Protalix Biotherapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 57, which is 33 points higher than the biotech industry average of 24.

AUPH passed 19 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 57.69% over the past year, overperforming other biotech stocks by 135 percentage points.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: B.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 76, which is 52 points higher than the biotech industry average of 24.

CPRX passed 25 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 59.67% over the past year, overperforming other biotech stocks by 137 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $33.20, an upside of 36.79% from Catalyst Pharmaceuticals's current stock price of $24.27.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Catalyst Pharmaceuticals, 60% have issued a Strong Buy rating, 40% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.27%, which is 4 percentage points higher than the biotech industry average of 1.81%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.46%, which is 1 percentage points higher than the biotech industry average of 1.81%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.5% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.32%, which is the same as the biotech industry average of 1.81%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 43.8% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.68% in the last day, and up 1.97% over the last week. Arvinas was the among the top losers in the biotechnology industry, dropping -24.84% yesterday.

Arvinas shares are trading lower. The company reported Q1 financial results.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -37.78% in the past year. It has overperformed other stocks in the biotech industry by 39 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -1.35% in the past year. It has overperformed other stocks in the biotech industry by 76 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 6.23% in the past year. It has overperformed other stocks in the biotech industry by 83 percentage points.

Are biotech stocks a good buy now?

54.79% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 102% over the next year.

1.74% of biotech stocks have a Zen Rating of A (Strong Buy), 4.13% of biotech stocks are rated B (Buy), 42.39% are rated C (Hold), 35.87% are rated D (Sell), and 15.87% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -169.39x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.